Inventor
Philipp Rubenbauer
Inventor
DE
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07BGeneral methods of organic chemistry19%
C07DHeterocyclic compounds19%
C07CAcyclic or carbocyclic compounds13%
Y02PClimate change mitigation technologies in the production or processing of goods13%
PatentTitleYear
12,258,343Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine202511,365,179Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone202211,344,519Orally administrable modified-release pharmaceutical dosage form202211,332,435Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to Bayer Pharma AG (4)· patent assignee history
2022–2025Patents assigned to BAYER AG (3)· patent assignee history
2022–2025Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 4 | 2022–2025 |
| BAYER AG | 3 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 4 | 2022–2025 |